Skip to main content
TipRanks
Go Ultimate75% OFF

Strata Critical Medical (SRTA) Stock Price & Analysis

1,019 Followers

SRTA Stock Chart & Stats

$5.51-$0.26(-4.51%)
At close: 4:00 PM EST
$4.5$5$5.5$6Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$5.50 - $5.78
52-Week Range
$3.95 - $6.50
Previous Close
$5.77
Volume
N/A
Average Volume (3M)
1.13M
Market Cap
$492.15M
Enterprise Value
$412.80M
Total Cash (Recent Filing)
$41.64M
Total Debt (Recent Filing)
$3.62M
Price to Earnings (P/E)
―
Beta
1.95
Next Earnings
Mar 16, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue And Gross Profit Growth

Robust revenue and gross profit growth indicate expanding demand and successful contribution from clinical acquisitions. The improvement also increases operating leverage and provides a stronger base for future margin expansion, supporting durable earnings growth over the next several quarters.

Very Low Financial Leverage

Minimal leverage gives Strata substantial financial flexibility while it works toward consistent profitability. A lightly indebted balance sheet reduces interest burden and refinancing exposure, allowing more internally generated cash and liquidity to support acquisitions, operations, or strategic investment.

Reaffirmed Growth And Cash-flow Targets

Reaffirmed guidance provides evidence that management continues to see a credible path toward higher revenue, EBITDA, and cash generation. Its medium-term targets and expected clinical-led growth could improve scale, mix, and free-cash-flow conversion if execution remains consistent.

Bears Say

TTM Profitability Remains Negative

Persistent operating and net losses show that the business has not yet converted revenue growth into durable GAAP earnings. Negative profitability limits internally funded expansion, weakens return generation, and leaves results more dependent on successful margin improvement and acquisition execution.

Uneven Free-cash-flow Conversion

Positive operating cash flow is encouraging, but very limited free cash flow indicates that cash conversion remains inconsistent after investment needs. This reduces the funds available for acquisitions and shareholder returns and makes the company more exposed to execution setbacks while profitability is still developing.

Logistics Revenue And Margin Pressure

Shorter donor-to-recipient distances directly reduce logistics revenue opportunities and pressure margins on owned aircraft. If this operating mix persists, the logistics segment may contribute less profit and offset some benefits from clinical growth, complicating consolidated margin expansion.

Strata Critical Medical News

SRTA FAQ

What was Strata Critical Medical’s price range in the past 12 months?
Strata Critical Medical lowest stock price was $3.95 and its highest was $6.50 in the past 12 months.
What is Strata Critical Medical’s market cap?
Strata Critical Medical’s market cap is $492.15M.
When is Strata Critical Medical’s upcoming earnings report date?
Strata Critical Medical’s next earnings report is estimated for Mar 16, 2027 (not yet confirmed), which is in 119 days.
How were Strata Critical Medical’s earnings last quarter?
Strata Critical Medical released its earnings results on Nov 03, 2026. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.008 by -$0.082.
Is Strata Critical Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Strata Critical Medical pay dividends?
Strata Critical Medical does not currently pay dividends.
What is Strata Critical Medical’s EPS estimate?
Strata Critical Medical’s EPS estimate is 0.01.
How many shares outstanding does Strata Critical Medical have?
Strata Critical Medical has 89,319,855 shares outstanding.
What happened to Strata Critical Medical’s price movement after its last earnings report?
Strata Critical Medical reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.008. Following the earnings report the stock price went up 3.738%.
Which hedge fund is a major shareholder of Strata Critical Medical?
Hedge funds hold Strata Critical Medical shares: the largest hedge-fund position in Strata Critical Medical is 71,886,713 shares, and hedge funds decreased their holdings by 4.1M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology